Effects of a new selective β3‐adrenoceptor agonist, vibegron, on bladder and urethral function in a rat model of Parkinson's disease
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effects of a new selective β3‐adrenoceptor agonist, vibegron, on bladder and urethral function in a rat model of Parkinson's disease
Authors
Keywords
-
Journal
LUTS-Lower Urinary Tract Symptoms
Volume 15, Issue 6, Pages 265-270
Publisher
Wiley
Online
2023-09-18
DOI
10.1111/luts.12503
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mechanisms of D1/D2-like dopaminergic agonist, rotigotine, on lower urinary tract function in rat model of Parkinson’s disease
- (2022) Mifuka Ouchi et al. Scientific Reports
- Additive effects of intravenous and intravesical application of vibegron, a β3-adrenoceptor agonist, on bladder function in rats with bladder overactivity
- (2020) Akira Furuta et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Animal Model for Lower Urinary Tract Dysfunction in Parkinson’s Disease
- (2020) Takeya Kitta et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Dopaminergic urethral closure mechanisms in a rat model of Parkinson's disease
- (2019) Mifuka Ouchi et al. NEUROUROLOGY AND URODYNAMICS
- Initial report on distribution of β3‐adrenoceptor in the human female urethra
- (2019) Maxime T. Kummeling et al. NEUROUROLOGY AND URODYNAMICS
- Long-term Outcome of Adenosine A2A Receptor Antagonist on Lower Urinary Tract Symptoms in Male Parkinson Disease Patients
- (2018) Takeya Kitta et al. CLINICAL NEUROPHARMACOLOGY
- Vibegron, a Novel Potent and Selective β 3 -Adrenoreceptor Agonist, for the Treatment of Patients with Overactive Bladder: A Randomized, Double-blind, Placebo-controlled Phase 3 Study
- (2018) Masaki Yoshida et al. EUROPEAN UROLOGY
- Long-term safety and efficacy of the novel β3 -adrenoreceptor agonist vibegron in Japanese patients with overactive bladder: A phase III prospective study
- (2018) Masaki Yoshida et al. INTERNATIONAL JOURNAL OF UROLOGY
- Treatment Options for Urogenital Dysfunction in Parkinson’s Disease
- (2016) Amit Batla et al. Current Treatment Options in Neurology
- The impact of non-motor symptoms on the quality of life of Parkinson's disease patients: a longitudinal study
- (2016) K. M. Prakash et al. EUROPEAN JOURNAL OF NEUROLOGY
- Discovery of Vibegron: A Potent and Selective β3 Adrenergic Receptor Agonist for the Treatment of Overactive Bladder
- (2016) Scott D. Edmondson et al. JOURNAL OF MEDICINAL CHEMISTRY
- Pharmacological Characterization of a Novel Beta 3 Adrenergic Agonist, Vibegron: Evaluation of Antimuscarinic Receptor Selectivity for Combination Therapy for Overactive Bladder
- (2016) J. Di Salvo et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Role of the Anterior Cingulate Cortex in the Control of Micturition Reflex in a Rat Model of Parkinson's Disease
- (2016) Takeya Kitta et al. JOURNAL OF UROLOGY
- Brain-bladder control network: The unsolved 21st century urological mystery
- (2015) Takeya Kitta et al. INTERNATIONAL JOURNAL OF UROLOGY
- Parkinson's disease
- (2015) Lorraine V Kalia et al. LANCET
- A guideline for the management of bladder dysfunction in Parkinson's disease and other gait disorders
- (2015) Ryuji Sakakibara et al. NEUROUROLOGY AND URODYNAMICS
- A Review of Lower Urinary Tract Symptoms in Patients with Parkinson’s Disease
- (2014) Anand V. Badri et al. Current Urology Reports
- Is overactive bladder a brain disease? The pathophysiological role of cerebral white matter in the elderly
- (2013) Ryuji Sakakibara et al. INTERNATIONAL JOURNAL OF UROLOGY
- Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease
- (2011) Susan Duty et al. BRITISH JOURNAL OF PHARMACOLOGY
- Persistence and adherence in the treatment of overactive bladder syndrome with anticholinergic therapy: a systematic review of the literature
- (2011) C. C. Sexton et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Animal research: Reporting in vivo experiments: The ARRIVE guidelines
- (2010) Carol Kilkenny et al. BRITISH JOURNAL OF PHARMACOLOGY
- Basic Mechanisms of Urgency: Preclinical and Clinical Evidence
- (2009) Martin C. Michel et al. EUROPEAN UROLOGY
- Changes in Prevalence and Incidence of Parkinson’s Disease in Japan during a Quarter of a Century
- (2009) Mika Yamawaki et al. NEUROEPIDEMIOLOGY
- L-dopa therapy for Parkinson's disease: Past, present, and future
- (2009) Toshiharu Nagatsu et al. PARKINSONISM & RELATED DISORDERS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search